Patient Guide: Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 391 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05742802
Status: 🟢 Enrolling Now
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Phase: PHASE3

Where You Can Participate

This study is available at 391 locations across the country.

Top locations include:
  • • Huntsville, Alabama
  • • Sheffield, Alabama
  • • Tempe, Arizona
  • • And 388 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO). - Join Clinical Trial NCTNCT05742802

How to Join This Clinical Trial - NCTNCT05742802

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Obstructive Pulmonary Disease (COPD). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Obstructive Pulmonary Disease (COPD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Obstructive Pulmonary Disease (COPD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05742802 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 391 locations. Find a study site near you:

Clinical Research Site

Huntsville, Alabama 35801 - United States

Status: WITHDRAWN

Clinical Research Site

Sheffield, Alabama 35660 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Tempe, Arizona 85283 - United States

Status: RECRUITING

Clinical Research Site

Bakersfield, California 93301 - United States

Status: WITHDRAWN

Clinical Research Site

Lincoln, California 95648 - United States

Status: RECRUITING

Clinical Research Site

Newport Beach, California 92663 - United States

Status: RECRUITING

Clinical Research Site

Northridge, California 91324 - United States

Status: COMPLETED

Clinical Research Site

Boynton Beach, Florida 33435 - United States

Status: RECRUITING

Clinical Research Site

Cape Coral, Florida 33990 - United States

Status: RECRUITING

Clinical Research Site

Ormond Beach, Florida 32174 - United States

Status: ACTIVE_NOT_RECRUITING

And 381 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Obstructive Pulmonary Disease (COPD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships